CNS Drugs
Description
CNS Drugs provides researchers and healthcare professionals with essential information on the most important aspects of drug therapies used for the management of neurological and psychiatric disorders.
Via a program of reviews and original research articles, the journal addresses major issues relating to drug therapy of these disorders, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of neurological and psychiatric disorders; and the practical management of specific clinical situations. Articles published in CNS Drugs may be accompanied by lay-level summaries to assist patients, caregivers and others in understanding important medical advances.
Latest Articles
-
Original Research Article
Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study
Richard H. Weisler, Michael Greenbaum, Valerie Arnold, Ming Yu, Brian Yan… (July 2017)
-
Therapy in Practice
Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension
Jacquie Baker, Kurt Kimpinski (July 2017)
-
Review Article
Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts
Enrico Franceschi, Santino Minichillo, Alba A. Brandes (July 2017)
- Impact Factor 4.394
- Available 1994 - 2017
- Volumes 31
- Issues 302
- Articles 2,059
- Open Access 65 Articles
Stay up to Date
Find a Volume or Issue
- Journal Title
- CNS Drugs
- Coverage
- Volume 1 / 1994 - Volume 31 / 2017
- Print ISSN
- 1172-7047
- Online ISSN
- 1179-1934
- Publisher
- Springer International Publishing
- Additional Links
- Topics
- Industry Sectors
Continue reading...
To view the rest of this content please follow the download PDF link above.